H. Riehm

Pulses of vincristine and dexamethasone in addition to intensive chemotherapy for children with intermediate-risk acute lymphoblastic leukaemia: a multicentre randomised trial (2007)

CONTER, V, VALSECCHI, MG, SILVESTRI, D, CAMPBELL, M, DIBAR, E, MAGYAROSY, E, ...

Secondary cytogenetic aberrations in childhood Philadelphia chromosome positive acute lymphoblastic leukemia are nonrandom and may be associated with outcome (2004)

Heerema, N.A., Harbott, J., Galimberti, S., Camitta, B.M., Gaynon, P.S., Janka-Schaub, G., ...

Additional chromosomal aberrations occur frequently in Philadelphia chromosome positive (Ph+) acute lymphoblastic leukemia (ALL) of childhood. The treatment outcome of these patients is...

Clinical heterogeneity in childhood acute lymphoblastic leukemia with 11q23 rearrangements (2003)

Pui, C.H., Chessells, J.M., Camitta, B., Baruchel, A., Biondi, A., Boyett, J.M., ...

To assess the clinical heterogeneity among patients with acute lymphoblastic leukemia (ALL) and various 11q23 abnormalities, we analyzed data on 497 infants, children and young adults treated between...

Detection of minimal residual disease identifies differences in treatment response between T-ALL and precursor B-ALL (2002)

Willemse, M.J., Hop, W.C., Panzer-Grumayer, E.R., Biondi, A., Dongen, J.J. Van, Schrappe, M., ...

We performed sensitive polymerase chain reaction-based minimal residual disease (MRD) analyses on bone marrow samples at 9 follow-up time points in 71 children with T-lineage acute lymphoblastic...

Intensive traetment of children with acute leukemia according to ALL-BFM-86 without cranial radiotherapy: results of Dutch childhood leukemia study group protocol ALL-7 (1988-1991) (1999)

Kamps, W.A., Bokkerink, J.P.M/, Hahlen, K., Hermans, J., Riehm, H., Gadner, H., ...

Abstract (1992)

Strohscheer, I., Kleinert, R., Westphal, C., Schüller, J., Werner, K., Anders, O., ...

Peer Reviewed

Original article: Comparative results of two intensive treatment programs for childhood acute lymphoblastic leukemia: The Berlin-Frankfurt-Munster and Dana-Farber Cancer Institute protocols (1991)

Niemeyer, C. M., Reiter, A., Riehm, H., Donnelly, M., Gelber, R. D., Sallan, S. E.

We analyzed two of the most successful trials for childhood acute lymphoblastic leukemia, from the Berlin-Frankfurt-Munster group (BFM) and the Dana-Farber Cancer Institute (DFCI), to determine their...